Projects

Utility of drug patch testing in cutaneous adverse drug reactions

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2022 - 2025

Project Lead

Dr. Sowmya Kaimal

Authors

Dr. Sowmya Kaimal, Dr. Carol Lobo, Dr. Sanjana Mathew

Project Status

completed

Project Type

Funded (RGUHS grant)